🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. To determine the effect of Golimumab treatment on the number and functio...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2010-10
Trial ID
NCT01212653
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of go...
Status
Completed
Location
UC Denver-Colorado Barbara Davis Center, University of Colorado SOM Pediatric Endocrinology
Start Date
2017-10-16
Trial ID
NCT03298542
The primary purpose of this study is to determine if golimumab can preserve...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-26
Trial ID
NCT02846545
The purpose of this study is to evaluate the efficacy of intravenously (adm...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-03
Trial ID
NCT02186873
The purpose of this study is to evaluate the efficacy and safety of switchi...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01004432
Treatments Being Tested
The purpose of this study is to assess the effects (good and bad) of golimu...
Status
Terminated
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT00488774
Treatments Being Tested
The SPARTACUS study will explore the therapeutic efficacy of 2 different tr...
Status
Active Not Recruiting
Location
ASZ Aalst
Start Date
2020-08-24
Trial ID
NCT04435288
The purpose of this study is to assess the safety and efficacy of golimumab...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00488631
Treatments Being Tested
Primary Objective: \- To demonstrate that sarilumab (SAR153191/REGN88) on ...
Status
Terminated
Location
Investigational Site Number 840026
Start Date
2010-11
Trial ID
NCT01217814
Treatments Being Tested
This study tests the safety and effectiveness of ustekinumab or golimumab c...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00955279
Treatments Being Tested